Literature DB >> 16882497

Malignant pheochromocytoma.

Rasa Zarnegar1, Electron Kebebew, Quan-Yang Duh, Orlo H Clark.   

Abstract

Malignant pheochromocytoma is a rare disease with a high mortality. Surgical resection is the only effective treatment if extensive metastatic disease is not present. However, differentiating between benign and malignant pheochromocytoma is impossible in the absence of locoregional invasion or distant metastasis. This diagnostic dilemma has several drawbacks, including later detection and treatment of recurrence than if malignancy is determined at the original operation. With emerging molecular markers of malignant disease, optimal extent and approach for surgical treatment and appropriate extent of follow up could be established based on specific tumor behavior and the need for additional systemic therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882497     DOI: 10.1016/j.soc.2006.05.009

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  20 in total

1.  Malignant pheochromocytoma: new malignancy criteria.

Authors:  Pierre de Wailly; Luigi Oragano; Francois Radé; Anthony Beaulieu; Vincent Arnault; Pierre Levillain; Jean Louis Kraimps
Journal:  Langenbecks Arch Surg       Date:  2011-11-09       Impact factor: 3.445

2.  Identification of miRNAs as potential new biomarkers for nervous system cancer.

Authors:  Yong Wang; Jinchuan Liang; Cuili Di; Guiliang Zhao; Yaqun Zhao
Journal:  Tumour Biol       Date:  2014-08-20

3.  The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma.

Authors:  E Patterson; R Webb; A Weisbrod; B Bian; M He; L Zhang; A K Holloway; R Krishna; N Nilubol; K Pacak; E Kebebew
Journal:  Endocr Relat Cancer       Date:  2012-04-10       Impact factor: 5.678

4.  Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery.

Authors:  Pavel Nockel; Mustapha El Lakis; Apostolos Gaitanidis; Lily Yang; Roxanne Merkel; Dhaval Patel; Naris Nilubol; Tamara Prodanov; Karel Pacak; Electron Kebebew
Journal:  Surgery       Date:  2017-11-07       Impact factor: 3.982

Review 5.  Malignant pheochromocytomas and paragangliomas: a diagnostic challenge.

Authors:  Oliver Gimm; Catherine DeMicco; Aurel Perren; Francesco Giammarile; Martin K Walz; Laurent Brunaud
Journal:  Langenbecks Arch Surg       Date:  2011-11-29       Impact factor: 3.445

6.  A novel mutation of the succinate dehydrogenase B gene in a Korean family with pheochromocytoma.

Authors:  Sang Ah Lee; Eun Hee Kim; Yu Mi Lee; Woochang Lee; Won Ki Min; Young-Joo Lee; Joo Ryung Huh; Woo Je Lee
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

7.  SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma.

Authors:  Yasmine Assadipour; Samira M Sadowski; Meghna Alimchandani; Martha Quezado; Seth M Steinberg; Naris Nilubol; Dhaval Patel; Tamara Prodanov; Karel Pacak; Electron Kebebew
Journal:  Surgery       Date:  2016-11-10       Impact factor: 3.982

8.  Malignant giant pheochromocytoma: a case report and review of the literature.

Authors:  Cristina Torres Arcos; Virgilio Ruiz Luque; José Aguilar Luque; Pablo Martínez García; Antonia Brox Jiménez; Macarena Márquez Muñoz
Journal:  Can Urol Assoc J       Date:  2009-12       Impact factor: 1.862

9.  Robotic-assisted partial cystectomy for recurrent extra-adrenal pheochromocytoma.

Authors:  G Jayram; L E Msezane; P Angelos; S E Eggener
Journal:  J Robot Surg       Date:  2009-01-27

10.  Response after surgical resection of metastatic pheochromocytoma and paraganglioma: can postoperative biochemical remission be predicted?

Authors:  Ryan J Ellis; Dhaval Patel; Tamara Prodanov; Samira Sadowski; Naris Nilubol; Karen Adams; Seth M Steinberg; Karel Pacak; Electron Kebebew
Journal:  J Am Coll Surg       Date:  2013-07-25       Impact factor: 6.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.